EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:29673 - rifamycin SV
| Formula | C37H47NO12 |
| Net Charge | 0 |
| Average Mass | 697.778 |
| Monoisotopic Mass | 697.30983 |
| SMILES | CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C |
| InChI | InChI=1S/C37H47NO12/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46)/b11-10+,14-13+,17-12-/t16-,18+,19+,20+,25-,29-,30+,33+,37-/m0/s1 |
| InChIKey | HJYYPODYNSCCOU-ODRIEIDWSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Amycolatopsis mediterranei (ncbitaxon:33910) | - | PubMed (25256628) | Strain: OVA5-E7 |
| Roles Classification |
|---|
| Biological Roles: | antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. |
| Applications: | antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| rifamycin SV (CHEBI:29673) has role antimicrobial agent (CHEBI:33281) |
| rifamycin SV (CHEBI:29673) has role antispasmodic drug (CHEBI:53784) |
| rifamycin SV (CHEBI:29673) has role antitubercular agent (CHEBI:33231) |
| rifamycin SV (CHEBI:29673) has role bacterial metabolite (CHEBI:76969) |
| rifamycin SV (CHEBI:29673) has role ophthalmology drug (CHEBI:66981) |
| rifamycin SV (CHEBI:29673) is a acetate ester (CHEBI:47622) |
| rifamycin SV (CHEBI:29673) is a cyclic ketal (CHEBI:59779) |
| rifamycin SV (CHEBI:29673) is a lactam (CHEBI:24995) |
| rifamycin SV (CHEBI:29673) is a macrocycle (CHEBI:51026) |
| rifamycin SV (CHEBI:29673) is a organic heterotetracyclic compound (CHEBI:38163) |
| rifamycin SV (CHEBI:29673) is a polyphenol (CHEBI:26195) |
| rifamycin SV (CHEBI:29673) is a rifamycins (CHEBI:26580) |
| rifamycin SV (CHEBI:29673) is conjugate acid of rifamycin SV(1−) (CHEBI:84571) |
| Incoming Relation(s) |
| rifamycin SV hemiaminal (CHEBI:142732) has functional parent rifamycin SV (CHEBI:29673) |
| rifamycin SV(1−) (CHEBI:84571) is conjugate base of rifamycin SV (CHEBI:29673) |
| IUPAC Name |
|---|
| (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate |
| INNs | Source |
|---|---|
| rifamicina | ChemIDplus |
| rifamycin | KEGG DRUG |
| rifamycine | ChemIDplus |
| rifamycinum | ChemIDplus |
| Synonyms | Source |
|---|---|
| M-14 | ChEMBL |
| Rifamicine sv | ChEMBL |
| rifamycin | ChEMBL |
| Rifamycin | KEGG COMPOUND |
| Rifamycin SV | KEGG COMPOUND |
| Rifocin | ChemIDplus |
| Citations |
|---|